WebMar 24, 2024 · View real-time CYTO stock price and news, along with industry-best analysis. Complete Altamira Therapeutics Ltd. stock information by Barron's. Search … WebApr 12, 2024 · The trading price of Altamira Therapeutics Ltd. (NASDAQ:CYTO) closed lower on Tuesday, April 11, closing at $1.32, -36.23% lower than its previous close. ... The stats also highlight that short interest as of Mar 14, 2024, stood at 0.32 million shares, resulting in a short ratio of 0.2 at that time. From this, we can conclude that short ...
Altamira Therapeutics Ltd. (CYTO) - Yahoo Finance
WebJul 24, 2024 · Cytochrome P450 (CYP450) tests: Your doctor may use cytochrome P450 (CYP450) tests to help determine how your body processes (metabolizes) a drug. The human body contains P450 enzymes to process medications. Because of inherited (genetic) traits that cause variations in these enzymes, medications may affect each person … WebAltamira Therapeutics Ltd. (NASDAQ:CYTO – Get Rating) was the target of a large decrease in short interest in January. As of January 31st, there was short interest … change the kb of image
CYTO Altamira Therapeutics Ltd. Stock Overview (U.S.: …
WebCYTO is not currently paying a regular dividend. Latest Dividend N/A Ex-Dividend Date N/A Short Interest (02/28/23) Shares Sold Short 24,051 Change from Last 60.95% Percent … WebAltamira Therapeutics Ltd. engages in developing therapeutics that address various unmet medical needs. Its commercial products include Bentrio, a drug-free nasal spray for personal protection against airborne viruses and allergens. The company is also involved in the development of RNA therapeutics for extrahepatic therapeutic targets ... WebApr 6, 2024 · A high-level overview of Altamira Therapeutics Ltd. (CYTO) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and … hardy sempervivum